|Arterial structure and function in mild primary hyperparathyroidism is not directly related to parathyroid hormone, calcium, or vitamin D.|
|Jump to Full Text|
|PMID: 22815708 Owner: NLM Status: MEDLINE|
|OBJECTIVE: Elevated levels of calcium and parathyroid hormone (PTH), characteristics of primary hyperparathyroidism (PHPT), may be associated with cardiovascular morbidity and mortality in the general population. We evaluated the possible vascular effects of these risk factors in patients with mild PHPT by using standard methods and new imaging techniques.
DESIGN: A prospective case-control study.
SUBJECTS AND METHODS: Forty-eight patients with mild PHPT without any known cardiovascular risk factors were studied at baseline and at one year after parathyroidectomy (PTX) in comparison with 48 healthy age- and gender-matched controls. We measured biochemical variables, augmentation index (AIx), aortic pulse wave velocity (PWV(ao)), radial (IMT(rad)) and common carotid artery (IMT(cca)) intima media thicknesses, and the grayscale median (IM-GSM) of the latter.
RESULTS: No significant differences were observed between PHPT patients and controls at baseline for AIx (28.6±12.2 vs. 27.7±12.8%), IMT(rad) (0.271±0.060 vs. 0.255±0.053 mm), IMT(cca) (0.688±0.113 vs. 0.680±0.135 mm), or IM-GSM (82.3±17.2 vs. 86.5±15.3), while PWV(ao) was slightly higher in patients (8.68±1.50 vs. 8.13±1.55, p<0.05). Systolic blood pressure (SBP), calcium, and PTH were higher in patients compared with controls, and decreased after PTX, while vitamin D was lower in patients and increased after PTX. While AIx, PWV(ao), IMT(rad), and IMT(cca) were related to SBP, neither correlated to vitamin D levels. Only PWV(ao) correlated weakly to plasma PTH (r = 0.29, p<0.01) and ionized calcium (r = 0.22, p<0.05) but showed no relation when age and SBP were adjusted for.
CONCLUSION: We found normal arterial function despite high calcium, PTH, and low vitamin D levels, in patients with mild PHPT without cardiovascular risk factors. The cardiovascular risk associated with low vitamin D and/or high PTH and calcium levels may be explained by their coupling to blood pressure and other risk factors rather than direct effects on arterial structure.
|Margareta Ring; Parastou Farahnak; Tomas Gustavsson; Inga-Lena Nilsson; Maria J Eriksson; Kenneth Caidahl|
Related Documents :
|17052418 - Gastric stromal tumors: clinical presentations, diagnosis and outcome.
17614968 - Plasma acylated ghrelin levels are higher in patients with chronic atrophic gastritis.
18661018 - Prevalence of oral mucosa lesions in diabetic patients: a preliminary study.
10189848 - Clinical symptoms, hormone profiles, treatment, and prognosis in patients with gastric ...
6730008 - Tuberculosis peritonitis: diagnostic value of the ascitic/blood glucose ratio.
17185688 - Effectiveness of an aggressive antibiotic regimen for chemoembolization in patients wit...
|Type: Journal Article; Research Support, Non-U.S. Gov't Date: 2012-07-16|
|Title: PloS one Volume: 7 ISSN: 1932-6203 ISO Abbreviation: PLoS ONE Publication Date: 2012|
|Created Date: 2012-07-20 Completed Date: 2013-03-26 Revised Date: 2013-07-12|
Medline Journal Info:
|Nlm Unique ID: 101285081 Medline TA: PLoS One Country: United States|
|Languages: eng Pagination: e39519 Citation Subset: IM|
|Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden. email@example.com|
|APA/MLA Format Download EndNote Download BibTex|
Arteries / pathology*, physiopathology*
Calcium / metabolism
Carotid Arteries / pathology, physiopathology
Hyperparathyroidism, Primary / metabolism*, pathology, physiopathology, surgery
Parathyroid Hormone / metabolism
Radial Artery / pathology, physiopathology
Tunica Intima / pathology, physiopathology
Vitamin D / metabolism
|0/Parathyroid Hormone; 1406-16-2/Vitamin D; 7440-70-2/Calcium|
Journal ID (nlm-ta): PLoS One
Journal ID (iso-abbrev): PLoS ONE
Journal ID (publisher-id): plos
Journal ID (pmc): plosone
Publisher: Public Library of Science, San Francisco, USA
Ring et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Received Day: 15 Month: 2 Year: 2012
Accepted Day: 26 Month: 5 Year: 2012
collection publication date: Year: 2012
Electronic publication date: Day: 16 Month: 7 Year: 2012
Volume: 7 Issue: 7
E-location ID: e39519
PubMed Id: 22815708
Publisher Id: PONE-D-12-04989
|Arterial Structure and Function in Mild Primary Hyperparathyroidism Is Not Directly Related to Parathyroid Hormone, Calcium, or Vitamin D Alternate Title:Arterial Function in Primary Hyperparathyroidism|
|Maria J. Eriksson12|
1Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
2Karolinska University Hospital, Stockholm, Sweden
3Department of Clinical Science and Education, Section of Surgery, Karolinska Institutet, Södersjukhuset, Stockholm, Sweden
4Chalmers University of Technology, Gothenburg, Sweden
|Medical University Innsbruck, Austria
|Correspondence: * E-mail: firstname.lastname@example.org
Contributed by footnote: Conceived and designed the experiments: ILN ME KC. Performed the experiments: MR PF ILN. Analyzed the data: MR PF KC MJE ILN. Contributed reagents/materials/analysis tools: TG. Wrote the paper: MR KC MJE ILN PF TG.
Associations between high calcium and parathyroid hormone (PTH) as well as low 25-OH-D levels and cardiovascular risk have been reported in the general population , , , . Recently, elevated PTH levels have been found to predict cardiovascular mortality in patients with coronary disease , as well as in the general population . However, other recent data indicate no association between low 25-OH-D levels and all-cause mortality in older men .
Primary hyperparathyroidism (PHPT) is characterized by elevated calcium levels, inappropriately increased PTH levels, and is often associated with vitamin D deficiency .
Thus, PHPT is a good model to determine the influence of these alterations on the vasculature.
An increased mortality rate has been noted in both unselected PHPT , as well as in mild PHPT . However, the majority of previous studies on PHPT include patients with varying disease severity in combination with pre-existing cardiovascular risk factors, which may confound relationships. Nevertheless, it is still unclear whether vascular structure and function are affected in mild PHPT without cardiovascular risk factors .
Endothelial function and vasodilatation regulated by nitride oxide (NO) release is of importance in the early atherosclerotic process. Endothelial vasodilatory dysfunction has been described in patients with PHPT . In studies of mild PHPT, the augmentation index (AIx), an indirect measure of the endothelial function and arterial stiffness, has been reported to be increased , . Increased pulse wave velocity (PWVao) has been found in PHPT patients with hypertension ; however, conflicting results are reported . Carotid intima-media thickness (IMTcca) measured by ultrasound is associated with a risk of myocardial infarction and stroke , . Alterations in carotid IMTcca have been reported in patients with mild PHPT , ; however the results are somewhat conflicting , . Among PHPT patients with or without cardiovascular risk factors, IMTcca was found to be increased only in the group with risk factors . Recently, echogenicity of the carotid intima media complex has been demonstrated to be related to cardiovascular risk factors , and the intima thickness of the radial artery (IMTrad) has been shown to be increased in hypertension , but none of these indices have yet been studied in PHPT.
With mild PHPT without concomitant disease or known cardiovascular risk factors as a model, our aim was to determine the potential effects of PTH, calcium, and vitamin D on arterial structure and function. Thus, applying the as mentioned novel diagnostic techniques, we compared patients with age- and gender matched healthy controls, and evaluated the vascular effects of normalizing PTH, calcium, and vitamin D by parathyroidectomy (PTX).
In a prospective, previously described , , case-control study at the Karolinska University Hospital in Stockholm, 410 PHPT patients (319 women) accepted for PTX between January 2006 and November 2008 were consecutively evaluated for possible participation. Patients accepted for PTX were included in the current study if they fulfilled the following criteria: calcium <3.0 mmol/L; no diagnosed hypertension, diabetes mellitus, or renal diseases; no medication affecting the cardiovascular system; no current smoking; BMI <28; and age >18 and <70 years. The majority of our patients had plasma calcium levels below 2.75 mmol/L, and only five patients had plasma calcium levels between 2.76–2.97 mmol/L at the time of inclusion. Fifty-three patients with mild PHPT were consecutively included in the study. Five of the 53 patients were excluded; one man due to later findings of familial hypocalciuric hypercalcaemia, one woman regretted her decision to undergo PTX, one man was excluded because of carotid image storage failure and finally, two men were excluded because of lipid lowering medication. The final population consisted of 48 patients (13 men and 35 women). Of these, 13 PHPT patients had a history of kidney stones (n = 9) and/or osteoporosis (n = 6); while the remaining 35 patients had no classical symptoms coupled to PHPT, 22 of whom were diagnosed with PHPT at a routine health check-up, and the others sought medical attention because of fatigue or diffuse symptoms.
A healthy control group, age- and gender-matched, was randomly selected from the population registry of the city of Stockholm. They were informed by mail and asked to participate in the study. If they fulfilled the inclusion criteria, described above, they were included in the study. If anyone declined, a new randomly chosen control from the population registry was contacted. Two controls were replaced before entering the study: one because of hypertension and the other because of a high PTH level. The median (25, 75 percentiles) time from baseline to follow-up was 1.06 and 1.48 years. One woman did not participate in the vascular examinations at follow-up. The blood pressure and all examinations were performed the morning after an over-night fast, with a resting period of 30–60 minutes in supine position. The same investigator performed the ultrasound examinations and pulse wave analysis. Each participant provided written consent to participate in the study, which was approved by the Local Ethics Committee, Regional Ethical Review Board, EPN, of Stockholm, Sweden.
Blood pressure (BP) was measured in both arms using a digital automatic blood pressure monitor Omron M7 (Omron Healthcare Co., LTD, Kyoto, Japan). The mean values of systolic and diastolic blood pressure (SBP and DBP) in both arms were calculated. Mean arterial blood pressure (MAP) was calculated as DBP + (SBP-DPB)/3. Body mass index (BMI) was calculated by dividing weight (kg) by the square of height (m2). Body surface area (BSA) was calculated by the formula: BSA (m2) = 0.007184 × (weight, kg)0.425 × (height, cm)0.725.
Augmentation index (AIx) and aortic pulse wave velocity (PWVao) were noninvasively measured using SphygmoCor equipment connected to a computer with SphygmoCor 2000 software (version 7.01, AtCor Medical, Sydney, Australia). Recordings were performed using a single high-fidelity tonometer gently pressed to the radial, carotid, and femoral arteries (SPT-301B, Millar Instruments, Houston, Texas, USA). To measure AIx, the radial artery waves were recorded and processed by the system software. The corresponding aortic pressure waveform was generated from an averaged radial artery waveform using a validated transfer factor , . AIx is defined as the difference between the first and the second peaks of the central aortic waveform, expressed as a percentage of the pulse pressure , . To obtain PWVao, the pulse waveform was collected sequentially from femoral and carotid artery sites, and by using the R- wave (of a simultaneously recorded electrocardiography, ECG) as a reference, the mean difference in time (ΔT) between sites A (carotid) and B (femoral) was calculated. The surface distance (xsubtracted) was measured as (carotid-jugulum distance) subtracted from (jugulum-femoral distance). The direct distance over the body surface (xdirect) was obtained by a standardized formula: xdirect = 0.45xsubtracted +0.21* height +0.08 (m) . The use of xdirect leads to an overestimation of the real PWVao, and a scaling factor was used to convert PWVao distance to “real” PWVao. The real PWVao was calculated as: 0.8* xdirect/ΔT, m/s, , , . The brachial artery blood pressure was measured in connection with the examination, as a mean value of two measurements, by using an automatic monitor Omron M7 (Omron Healthcare Co., LTD., Kyoto, Japan. The radial and aortic blood pressure was calibrated against the brachial artery blood pressure. The aortic AIx and PWVao are presented as mean values from two recordings.
Two-dimensional images of the common carotid artery (CCA) were acquired using an 8 MHz transducer, 7L, Vivid 7 (General Electric Company, Horten, Norway). The CCA was evaluated 1–2 cm proximal to the carotid bulb. Diastolic images at the time of the electrocardiographic R-wave were stored digitally on EchoPAC (Image Vault 5.0 system, General Electric Company, Horten, Norway). For detection of IMTcca and IM-GSM, six digitized images were imported to validated automated software, Artery Measurement Software (AMS) , . AMS was developed in collaboration between the Department of Signals and Systems at Chalmers University of Technology, and the Physiology group at the Wallenberg Laboratory (www.wlab.gu.se), Gothenburg University, Gothenburg, Sweden. A region of interest (ROI) of a 10 mm long segment was manually placed proximal to the carotid bulb, Figure 1, upper panel. The boarders of the IMTcca of the far wall and the inner lumen diameter (LDcca) were identified automatically by the program and the analysis could be manually corrected if necessary. IMTcca was defined as the distance from the leading edge of the lumen-intima interface to the leading edge of the media-adventitia of the far wall. LDcca was defined as the distance from the leading edge of the intima-lumen interface of the near wall and the leading edge of the lumen-intima interface of the far wall .
The IM-GSM was calculated in the same intima-media segment of the far wall that was evaluated for IMTcca, and from analysis of pixels on a scale from 0 (black) to 255 (white). The adventitia was used as the reference for white and the blood as the reference for black. IMTcca, IM-GSM, and LDcca are presented as mean values of six images from both the right and left CCA. Lumen diameter and IMTcca values are shown in mm, while IM-GSM is shown as median gray. At the end of the study, the same investigator performed the image analyses and calculations in random order. Intra- and interobserver variability was measured in 30 randomly selected participants, and the calculations in terms of coefficients of variation (CV) were: 2.90% and 3.80% for IMTcca, 0.40% and 0.70% for LDcca, and 2.74% and 3.81% for IM-GSM. Bland-Altman plots for IMTcca and IM-GSM are shown in Figure 2.
A high-resolution ultrasound investigation of the radial artery was performed in 43 patients. The images of the intima media of the radial artery were obtained by high-resolution ultrasound using a 55 MHz transducer (Vevo 770, VisualSonics, Toronto, Canada). B-mode images were recorded from the right radial artery in a longitudinal projection, 1–2 cm proximal to the fold separating the palm of the hand from the forearm. All cine-loops were stored on an external disk and measured offline using VisualSonics software. The thickness of the radial artery intima media (IMTrad) and lumen diameter (LDrad) were measured according to the leading edge principle . Three sets of measurements were performed from each of the three representative images. The IMTrad of the far wall is presented as a mean value from nine measurements corresponding to the end-diastole, the smallest lumen diameter. The IMTrad was defined as the distance from the lumen-intima interface to the media-adventitia interface, Figure 1, lower panel. Diastolic LDrad was measured from the M-mode image, defined by the distance between the intima-lumen interface of the near wall and the lumen-intima interface of the far wall. LDrad is presented as a mean value taken from three representative beats. Intra- and interobserver variability in terms of CV were 5.78 and 10.94% for IMTrad, and 3.16 and 3.56% for LDrad.
Plasma concentrations of total calcium, creatinine, glucose, high sensitivity C-reactive protein (hsCRP), phosphate, serum concentration of total cholesterol, triglycerides (TG), apolipoprotein A-1 (Apo-A1), and apolipoprotein B (Apo-B) were estimated using Synchron LX® 20 system (Beckman Coulter Inc., Brea, CA, USA). Serum-ionized calcium (Ca++) was analyzed on ABL 800 (Radiometer, Copenhagen, Denmark), and plasma concentration of intact parathyroid hormone (PTH) was measured with electro-chemiluminescence immunoassay on the Modular E system (Roche Diagnostics GmbH, Mannheim, Germany). Total serum IGF-1 was analyzed by chemiluminescence immunoassay on DPC Immulite 2000 (Siemens Healthcare Diagnostics, Munich, Germany). Serum concentrations of 25-OH-D were measured by chemiluminiscence on Liason® (DiaSorin, S.p.A, Italy). The plasma concentrations of VWF antigen were determined with latex immunoassay on the BCS XP system (Siemens Healthcare Diagnostics, Munich, Germany). The plasma activity of PAI-1 was measured by a functional enzymatic ELISA assay (Chromolyze PAI-1) from Medinor (Axis-Shield, Dundee, U.K.). The samples of 25 hydroxyvitamin D (25-OH-D), von Willebrand factor (VWF) antigen, and PAI-1 were frozen at −70°C and analyzed in the same series in order to minimize inter-assay variation. Renal function was estimated by calculating the glomerular filtration rate (GFR) according to Cockroft-Gault’s formula: GFR = (140-age in yr) x (weight in kg/creatinine) x (1.23 in men or 1.04 in women).
Vitamin D deficiency was defined as 25-OH-D below 50 nmol/L.
Statistical analyses were performed with PASW Statistics v18 (PASW Inc., Chicago, Illinois, U.S.A.). Data are expressed as mean ± SD. Comparisons between the patients at baseline and the control group were performed with the Mann-Whitney U test for unpaired data, and for intra-individual analyses, Wilcoxon signed rank sum test was used. Spearmańs rank correlation coefficients were computed to assess relationships between variables. Univariate and stepwise multiple linear regression analyses were used to evaluate relationships and adjust for confounders. Results from the multiple regression analyses were presented as standardized beta and adjusted R2.
The coefficient of variation (CV), defined as the standard deviation of the absolute differences between the measurements, divided by the mean of two measurements was used to evaluate the intra- and interobserver variability. The reproducibility was illustrated according to Bland-Altman . All tests were two-tailed and p<0.05 was considered to be statistically significant.
Clinical data of healthy controls as well as PHPT patients at baseline and follow-up are presented in Table 1. The patients mean age at baseline was 54±8.9 years (range 33 to 68 years). Fifteen patients were below 50 years of age. Forty-five patients had a single parathyroid adenoma, and three had multiglandular disease; median weight of removed tissue 409 mg. Heart rate and diastolic blood pressure did not differ, while systolic blood pressure was slightly higher in patients (p<0.05).
Biochemical data are presented in Table 2. Calcium and PTH levels were significantly higher and phosphate levels were lower in patients compared with controls and normalized after PTX. The vitamin D levels increased after surgery, but 19 out of 48 patients (40%) had a 25-OH-D level below 50 nmol/l at follow-up, 15±4 months after PTX. There were no significant differences between the subgroups with 25-OH-D levels <50 nmol/L, and >50 nmol/L, regarding SBP, AIx, PWVao, IMTcca, IMTrad, IM-GSM, S-Ca, ionized Ca, or PTH levels. Further, these measures did not differ between those with 25-OH-D levels below or above the median (39 nmol/L).
Vascular structural and functional results are presented in Table 3. We found no differences between patients and controls regarding AIx, estimated aortic blood pressure, IMTcca, IM-GSM values, or lumen of the CCA and no changes were observed during follow-up. PWVao was slightly higher in patients 8.68±1.50 (mean±SD) compared to controls 8.13±1.55 (mean±SD), p<0.05, (range 6.6–13.2 for patients and 5.3–13.3 for controls), and did not change during follow-up. The IMTrad did not differ between the groups and remained unchanged at follow-up, while the LDrad was similar to that of controls; however, a marginal increase was noted after one year (p<0.05).
We evaluated the univariate relations of vascular measures in terms of AIx, PWVao, IMTrad, IMTcca, and IM-GSM to baseline data in the complete study cohort of patients and controls in order to verify expected patterns, Table 4. As noted, all vascular data except IM-GSM were related to age and systolic blood pressure. Further, correlations of AIx, PWVao, IMTcca, IMTrad, and IM-GSM with biochemical variables are also presented in Table 4. Vascular function was not related to vitamin D. AIx and PWVao were weakly related to cholesterol, PWVao, and IM-GSM also to PTH, and PWVao to ionized Ca and triglycerides. None of AIx, PWVao, IMTrad, IMTcca, or IM-GSM correlated to P- Phosphate, hsCRP, Apo-B/Apo-A1, Ca*P product, or homocysteine levels.
Multiple stepwise regression analyses with indices of vascular function (AIx, PWVao, IMTcca, IMTrad and IM-GSM, one at a time) as dependent variables and demographic data (age, gender, SBP, height, and weight) as independent variables are presented in Table 5. More than 30% of the variation in AIx, PWVao, and IMTcca, were explained by age and SBP, in AIx also by gender.
We also analyzed the possible influence of the disease-specific biochemical disturbances (PTH, ionized Ca, phosphate, 25-OH-D) on the five indices of vascular function, one at a time, considering also demographic data, Table 6. Apart from a weak relation between AIx and phosphate, no vascular measure was related to the biochemical variables.
In this prospective case-control study of mild PHPT without any known cardiovascular risk factors or medications affecting the cardiovascular system, we found no indication that circulating levels of vitamin D influenced arterial structure or function. Wall composition (IM-GSM) and aortic stiffness (PWVao) were weakly related to PTH and the latter also to ionized calcium levels in univariate analysis, but not when adjusting for confounders like blood pressure. Furthermore, the PTX did not cause any change in indices of vascular function or arterial wall thickness. Our conclusions were substantiated by adding new variables, such as echogenicity of the carotid artery and intima media thickness of the radial artery to the established measures AIx, PWVao, and IMTcca.
Thus, although vitamin D deficiency is common in patients with PHPT , and is associated with cardiovascular disease in the general population , we did not observe any relations between 25-OH-D and AIx, PWVao, IMTrad, IMTcca, or IM-GSM in our study. Neither were these measures related to other biochemical data specifically abnormal in PHPT, such as Ca++ and phosphate, apart from a correlation between PWVao and PTH and ionized Ca and an inverse correlation between IM-GSM and PTH. Interestingly, Reis et al. found no association between vitamin D and carotid IMT apart from a weak association of 25-OH-D levels to internal carotid IMT when adjusting for, but not excluding, hypertension. Further, they found no evidence of an association between 1,25(OH)2 D and common carotid IMT or internal carotid IMT, apart from a weak association to internal carotid IMT among patients with hypertension in one of several subgroup analyses . The higher blood pressure among PHPT patients is not clearly understood. Despite the fact that we excluded patients with hypertension, we found significantly higher SBP, although within normal range, in patients compared with controls. SBP decreased after PTX in our patients, while it did not in another series of mild PHPT patients . We have previously reported a weak but significant correlation between SBP and Ca++ as well as PTH levels when including both patients and controls . It has been reported that vitamin D may influence blood pressure through the renin-angiotensin system , and a number of possible pathophysiological links to atherosclerosis have been ascribed to vitamin D deficiency, including activation of the renin angiotensin system . Our data add strength to the hypothesis that associations between the atherosclerotic process and circulating levels of vitamin D, ionized Ca, and PTH are mediated through blood pressure and other risk factors. With regard to the relation between vitamin D status and cardiovascular risk, many issues still remain to be resolved. Recent comprehensive reviews do not support a strong link between vitamin D status or supplementation and cardiometabolic outcome or cardiovascular events , , and another systematic review and meta-analysis, based on 51 trials, found no significant correlation between vitamin D status, hypertension, or cardiovascular mortality .
Interestingly, it was recently demonstrated that PHPT causes up- regulation of the matrix metallopeptidase 9 (MMP9) gene and a number of other inflammatory and metabolic genes in fat tissue, with possible impacts on blood pressure and atherosclerosis . In our study of normotensive PHPT patients and controls, we found slightly higher blood pressure and PWVao in patients. However, data are not unanimous. While Rosa et al. noted PHPT patients to have increased arterial stiffness with and without hypertension , Kosch et al. showed no difference in PWV between PHPT patients and controls, and found no correlations between PWV and increased PTH levels .
Our PHPT patients and healthy controls showed no difference in AIx. This is in contrast to the results of Smith et al. and Rubin et al., who also studied patients with mild PHPT. Smith et al. reported higher AIx in patients with mild PHPT compared to controls, and Rubin et al. asserted that PHPT was independently associated with increased AIx. In contrast to Rubin et al., we did not find any correlation between AIx and elevated PTH. A plausible explanation for the discrepancy is that Rubin et al. studied groups containing PHPT patients with hypertension and patients on cardiovascular medication. The association between the severity of PHPT and cardiovascular risk factors, however, is not universal. Similar amount of risk factors was recently reported in hypercalcemic and normocalcemic PHPT patients although cardiovascular and cerebrovascular diseases were more common in hypercalcemic PHPT . In the same study, however, vascular stiffness was not higher in this group than in normocalcemic PHPT or controls, and in congruence with our material unrelated to calcium and PTH.
Probably, cardiovascular diseases combined with PHPT are more likely to affect the arterial wall and IMT than PHPT alone. This is supported by Fallo et al., who included PHPT patients with and without cardiovascular risk factors. When compared to healthy controls, only PHPT patients with concomitant cardiovascular risk factors were found to have an increased IMT of the carotid artery wall. Similarly Walker et al. reported increased carotid IMT in PHPT patients, including those with cardiovascular diseases, compared to controls. Nuzzo et al. excluded subjects with high blood pressure or clinical cardiovascular disease and still found significantly higher carotid IMT values in 20 selected patients compared with controls. However, the authors did not indicate the lipid levels in their study group. Kosch et al. found no disturbance in brachial and carotid IMT or aortic PWV in PHPT patients compared to controls, and Lumachi et al. reports no improvement in carotid IMT after 18 months of PTX follow-up; further, no correlations between serum calcium and IMT was found. In our study, with careful exclusion of patients with cardiovascular risk factors, we did not observe any differences between patients and controls at baseline, apart from slightly higher SBP and PWVao in patients with a significant reduction in blood pressure one year after PTX. All our vascular measurements, apart from IM-GSM, were related to age and blood pressure. Adjusting for age and blood pressure, PWVao was not related to circulating levels of PTH, Ca++, phosphate, or 25-OH-D.
In order to investigate the vascular structure more thoroughly, we have used new validated techniques in our study, such as grayscale median for the evaluation of echogenicity of the carotid intima media, and a high- resolution ultrasound for measurement of IMT in the radial artery. We have demonstrated that high- resolution ultrasound allows measurement of very thin structures such as IMT of the rat carotid artery wall , and it has also been shown that measurement of the human radial artery IMT is feasible by this technique . In the current study, we measured the intima media thickness in the radial artery and found no significant increase in IMTrad in the PHPT patients compared with controls. By measurement of the grayscale in the intima media images of carotid artery, we tried to obtain information regarding the wall composition, with the assumption that fibrotic infiltration should be more echogenic and lipidous transformation should be more echolucent. Earlier studies have shown that IM-GSM in CCA is closely related to the echogenicity in overt carotid plaques; moreover, the same group further reported a relationship between echolucency in the intima-media complex and cardiovascular risk factors in elderly subjects , . However, our study did not indicate abnormal composition of the carotid artery wall as evaluated by this technique.
To our knowledge, this is the first study to describe IMTrad and the echogenicity in the intima media of the CCA in patients with mild PHPT. The strict design, excluding cardiovascular risk factors, is the strength of our study, which should favorably influence the reliability of our results. The material is comparatively large for this type of study; however, it is too small for any prognostic evaluations.
We measured the IMT of the common carotid artery in the far wall only, as we assumed relatively symmetrical wall thickness in our patients and controls. Since most patients with PHPT today do not express typical signs and since calcium- and PTH-levels are not examined routinely, it is rarely possible to estimate the duration of the disease.
We found normal arterial function, despite high PTH and Ca as well as low vitamin D levels, in patients with mild PHPT without cardiovascular risk factors. The cardiovascular risk associated with low vitamin D and/or high PTH and Ca levels may be explained by their coupling to blood pressure and other risk factors rather than direct effects on the arterial structure. Our findings support the importance of adequate blood pressure control in PHPT if PTX is not performed, but do not indicate vascular abnormalities motivating extended follow-up after PTX.
Competing Interests: The authors have declared that no competing interests exist.
Funding: This study was supported by grants from the Stockholm County Council, Karolinska Institutet, the Swedish Heart Lung Foundation, the Swedish Medical Research Council, Capio Research Foundation, and the Fredrik and Ingrid Thuring Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
The authors thank Ebba Lindqvist for skillful technical assistance, Peter Holdfeldt for software improvement and Elisabeth Berg for statistical advice.
|1.||Fraser A,Williams D,Lawlor DA. Year: 2010Associations of serum 25-hydroxyvitamin D, parathyroid hormone and calcium with cardiovascular risk factors: analysis of 3 NHANES cycles (2001–2006).PLoS One5e1388221085485|
|2.||Williams DM,Fraser A,Lawlor DA. Year: 2011Associations of vitamin D, parathyroid hormone and calcium with cardiovascular risk factors in US adolescents.Heart9731532021193684|
|3.||Lind L,Hanni A,Lithell H,Hvarfner A,Sorensen OH,et al. Year: 1995Vitamin D is related to blood pressure and other cardiovascular risk factors in middle-aged men.Am J Hypertens88949018541004|
|4.||Burgaz A,Byberg L,Rautiainen S,Orsini N,Hakansson N,et al. Year: 2011Confirmed hypertension and plasma 25(OH)D concentrations amongst elderly men.J Intern Med26921121821091810|
|5.||Pilz S,Tomaschitz A,Drechsler C,Ritz E,Boehm BO,et al. Year: 2010Parathyroid hormone level is associated with mortality and cardiovascular events in patients undergoing coronary angiography.Eur Heart J311591159820439261|
|6.||Hagstrom E,Ingelsson E,Sundstrom J,Hellman P,Larsson TE,et al. Year: 2010Plasma parathyroid hormone and risk of congestive heart failure in the community.Eur J Heart Fail121186119220797986|
|7.||Cawthon PM,Parimi N,Barrett-Connor E,Laughlin GA,Ensrud KE,et al. Year: 2010Serum 25-hydroxyvitamin D, parathyroid hormone, and mortality in older men.J Clin Endocrinol Metab954625463420631024|
|8.||Silverberg SJ,Shane E,Dempster DW,Bilezikian JP. Year: 1999The effects of vitamin D insufficiency in patients with primary hyperparathyroidism.Am J Med10756156710625024|
|9.||Hedback G,Oden A. Year: 1998Increased risk of death from primary hyperparathyroidism–an update.Eur J Clin Invest282712769615902|
|10.||Yu N,Donnan PT,Flynn RW,Murphy MJ,Smith D,et al. Year: 2010Increased mortality and morbidity in mild primary hyperparathyroid patients. The Parathyroid Epidemiology and Audit Research Study (PEARS).Clin Endocrinol (Oxf)73303420039887|
|11.||Silverberg SJ,Lewiecki EM,Mosekilde L,Peacock M,Rubin MR. Year: 2009Presentation of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop.J Clin Endocrinol Metab9435136519193910|
|12.||Nilsson IL,Aberg J,Rastad J,Lind L. Year: 1999Endothelial vasodilatory dysfunction in primary hyperparathyroidism is reversed after parathyroidectomy.Surgery1261049105510598187|
|13.||Smith JC,Page MD,John R,Wheeler MH,Cockcroft JR,et al. Year: 2000Augmentation of central arterial pressure in mild primary hyperparathyroidism.J Clin Endocrinol Metab853515351911061493|
|14.||Rubin MR,Maurer MS,McMahon DJ,Bilezikian JP,Silverberg SJ. Year: 2005Arterial stiffness in mild primary hyperparathyroidism.J Clin Endocrinol Metab903326333015769995|
|15.||Rosa J,Raska I Jr,Wichterle D,Petrak O,Strauch B,et al. Year: 2011Pulse wave velocity in primary hyperparathyroidism and effect of surgical therapy.Hypertens Res34(3)29630021107330|
|16.||Kosch M,Hausberg M,Barenbrock M,Posadzy-Malaczynska A,Kisters K,et al. Year: 2001Arterial distensibility and pulse wave velocity in patients with primary hyperparathyroidism before and after parathyroidectomy.Clin Nephrol5530330811334316|
|17.||O'Leary DH,Polak JF,Kronmal RA,Manolio TA,Burke GL,et al. Year: 1999Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group.N Engl J Med34014229878640|
|18.||Bots ML,Hoes AW,Koudstaal PJ,Hofman A,Grobbee DE. Year: 1997Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study.Circulation96143214379315528|
|19.||Nuzzo V,Tauchmanova L,Fonderico F,Trotta R,Fittipaldi MR,et al. Year: 2002Increased intima-media thickness of the carotid artery wall, normal blood pressure profile and normal left ventricular mass in subjects with primary hyperparathyroidism.Eur J Endocrinol14745345912370105|
|20.||Walker MD,Fleischer J,Rundek T,McMahon DJ,Homma S,et al. Year: 2009Carotid vascular abnormalities in primary hyperparathyroidism.J Clin Endocrinol Metab943849385619755478|
|21.||Lumachi F,Ermani M,Frego M,Pilon F,Filosa T,et al. Year: 2006Intima-media thickness measurement of the carotid artery in patients with primary hyperparathyroidism. A prospective case-control study and long-term follow-up.In Vivo2088789017203784|
|22.||Fallo F,Camporese G,Capitelli E,Andreozzi GM,Mantero F,et al. Year: 2003Ultrasound evaluation of carotid artery in primary hyperparathyroidism.J Clin Endocrinol Metab882096209912727960|
|23.||Andersson J,Sundstrom J,Gustavsson T,Hulthe J,Elmgren A,et al. Year: 2009Echogenecity of the carotid intima-media complex is related to cardiovascular risk factors, dyslipidemia, oxidative stress and inflammation: the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study.Atherosclerosis20461261819200993|
|24.||Myredal A,Gan LM,Osika W,Friberg P,Johansson M. Year: 2010Increased intima thickness of the radial artery in individuals with prehypertension and hypertension.Atherosclerosis20914715119804883|
|25.||Farahnak P,Larfars G,Sten-Linder M,Nilsson IL. Year: 2011Mild primary hyperparathyroidism: vitamin D deficiency and cardiovascular risk markers.J Clin Endocrinol Metab962112211821593116|
|26.||Farahnak P,Ring M,Caidahl K,Farnebo LO,Eriksson MJ,et al. Year: 2010Cardiac function in mild primary hyperparathyroidism and the outcome after parathyroidectomy.Eur J Endocrinol16346146720562163|
|27.||Karamanoglu M,O'Rourke MF,Avolio AP,Kelly RP. Year: 1993An analysis of the relationship between central aortic and peripheral upper limb pressure waves in man.Eur Heart J141601678449191|
|28.||Pauca AL,O'Rourke MF,Kon ND. Year: 2001Prospective evaluation of a method for estimating ascending aortic pressure from the radial artery pressure waveform.Hypertension3893293711641312|
|29.||O'Rourke MF. Year: 1971The arterial pulse in health and disease.Am Heart J826877024940223|
|30.||Laurent S,Cockcroft J,Van Bortel L,Boutouyrie P,Giannattasio C,et al. Year: 2006Expert consensus document on arterial stiffness: methodological issues and clinical applications.Eur Heart J272588260517000623|
|31.||Vermeersch SJ,Rietzschel ER,De Buyzere ML,Van Bortel LM,Gillebert TC,et al. Year: 2009Distance measurements for the assessment of carotid to femoral pulse wave velocity.J Hypertens272377238519898251|
|32.||Weber T,Ammer M,Rammer M,Adji A,O'Rourke MF,et al. Year: 2009Noninvasive determination of carotid-femoral pulse wave velocity depends critically on assessment of travel distance: a comparison with invasive measurement.J Hypertens271624163019531964|
|33.||Sugawara J,Hayashi K,Yokoi T,Tanaka H. Year: 2008Age-associated elongation of the ascending aorta in adults.JACC Cardiovasc Imaging173974819356510|
|34.||Boutouyrie P,Vermeersch SJ,Mattace-Raso FUS,Wilkinson I,Willum Hansen T,et al. Year: 2010Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: 'establishing normal and reference values'.Eur Heart J312338235020530030|
|35.||Wendelhag I,Liang Q,Gustavsson T,Wikstrand J. Year: 1997A new automated computerized analyzing system simplifies readings and reduces the variability in ultrasound measurement of intima-media thickness.Stroke28219522009368564|
|36.||Liang Q,Wendelhag I,Wikstrand J,Gustavsson T. Year: 2000A multiscale dynamic programming procedure for boundary detection in ultrasonic artery images.IEEE Trans Med Imaging1912714210784284|
|37.||Wendelhag I,Gustavsson T,Suurkula M,Berglund G,Wikstrand J. Year: 1991Ultrasound measurement of wall thickness in the carotid artery: fundamental principles and description of a computerized analysing system.Clin Physiol115655771769190|
|38.||Bland JM,Altman DG. Year: 1986Statistical methods for assessing agreement between two methods of clinical measurement.Lancet13073102868172|
|39.||Wang TJ,Pencina MJ,Booth SL,Jacques PF,Ingelsson E,et al. Year: 2008Vitamin D deficiency and risk of cardiovascular disease.Circulation11750351118180395|
|40.||Reis JP, von Muhlen D, Michos ED, Miller ER 3rd, Appel LJ, et alYear: 2009Serum vitamin D, parathyroid hormone levels, and carotid atherosclerosis.Atherosclerosis20758559019539290|
|41.||Persson A,Bollerslev J,Rosen T,Mollerup CL,Franco C,et al. Year: 2011Effect of surgery on cardiac structure and function in mild primary hyperparathyroidism.Clin Endocrinol (Oxf)7417418021044114|
|42.||Li YC,Qiao G,Uskokovic M,Xiang W,Zheng W,et al. Year: 2004Vitamin D: a negative endocrine regulator of the renin-angiotensin system and blood pressure.The Journal of steroid biochemistry and molecular biology89–90387392|
|43.||Brewer LC,Michos ED,Reis JP. Year: 2011Vitamin D in atherosclerosis, vascular disease, and endothelial function.Curr Drug Targets12546020795937|
|44.||Pittas AG,Chung M,Trikalinos T,Mitri J,Brendel M,et al. Year: 2010Systematic review: Vitamin D and cardiometabolic outcomes.Ann Intern Med15230731420194237|
|45.||Wang L,Manson JE,Song Y,Sesso HD. Year: 2010Systematic review: Vitamin D and calcium supplementation in prevention of cardiovascular events.Ann Intern Med15231532320194238|
|46.||Elamin MB,Abu Elnour NO,Elamin KB,Fatourechi MM,Alkatib AA,et al. Year: 2011Vitamin D and cardiovascular outcomes: a systematic review and meta-analysis.J Clin Endocrinol Metab961931194221677037|
|47.||Christensen MH,Dankel SN,Nordbo Y,Varhaug JE,Almas B,et al. Year: 2011Primary hyperparathyroidism influences the expression of inflammatory and metabolic genes in adipose tissue.PLoS One6e2048121698093|
|48.||Rosa J,Raska I Jr,Wichterle D,Petrak O,Strauch B,et al. Year: 2011Pulse wave velocity in primary hyperparathyroidism and effect of surgical therapy.Hypertens Res3429630021107330|
|49.||Tordjman KM,Yaron M,Izkhakov E,Osher E,Shenkerman G,et al. Year: 2010Cardiovascular risk factors and arterial rigidity are similar in asymptomatic normocalcemic and hypercalcemic primary hyperparathyroidism.Eur J Endocrinol16292593320421337|
|50.||Razuvaev A,Lund K,Roy J,Hedin U,Caidahl K. Year: 2008Noninvasive real-time imaging of intima thickness after rat carotid artery balloon injury using ultrasound biomicroscopy.Atherosclerosis19931031618190918|
|51.||Lind L,Andersson J,Ronn M,Gustavsson T. Year: 2007The echogenecity of the intima-media complex in the common carotid artery is closely related to the echogenecity in plaques.Atherosclerosis19541141417462652|
Table 1 Clinical data for healthy controls and patients with mild primary hyperparathyroidism before and after parathyroidectomy.
|Baseline||Follow-up||vs. Controls||vs. Follow-up|
|n = 48 (35 F)||n = 48 (35 F)||n = 48 (35 F)||p-value||p-value|
an = 47. Values are shown as means±SD. F = female, HR = heart rate, bpm = beats per minute, SBP = systolic blood pressure, DBP = diastolic blood pressure, MAP = mean arterial pressure, BSA = body surface area, BMI = body mass index.
Table 2 Biochemical data for healthy controls and patients with mild primary hyperparathyroidism before and after parathyroidectomy.
|Baseline||Follow-up||vs. Controls||vs. Follow-up|
|n = 48 (35 F)||n = 48 (35 F)||n = 48 (35 F)||p-value||p-value|
|P-PTH (10–65 ng/L)||44.0±12.5||120.0±40.4||49.6±15.7||<0.001||<0.001|
|P-Calcium (2.15–2.50 mmol/L)||2.29±0.08||2.61±0.12||2.27±0.08||<0.001||<0.001|
|S-Ca++ (1.15–1.33 mmol/L)||1.25±0.04||1.46±0.06||1.25±0.05||<0.001||<0.001|
|P-Phosphate (0.80–1.5 mmol/L)||1.06±0.17||0.85±0.16||1.01±0.17a||<0.001||<0.001|
|S-25-OH-D (75–250 nmol/L)||64.1±20.6b||40.6±17.1a||58.2±19.5||<0.001||<0.001|
|P-Creatinine (<90 µmol/L)||69.1±13.6||66.3±12.1a||68.1±15.9b||0.434||0.386|
|GFR, mL/min (>90 mL/min)||93.0±22.0||100.9±22.2a||103.1±27.7b||0.049||0.861|
|P-Glucose (4.0–6.0 mmol/L)||5.0±0.34a||5.0±0.46b||4.9±0.52a||0.523||0.471|
|P-hs-CRP (<3 mg/L)||1.14±1.22b||0.92±0.90a||1.95±5.05c||0.553||0.004|
|S-Cholesterol (3.9–7.8 mmol/L)||5.71±1.03b||5.74±0.80a||5.85±0.89||0.857||0.163|
|S-TG (0.45–2.6 mmol/L)||0.86±0.43b||1.00±0.54a||0.93±0.51||0.073||0.045|
|S-Apo-A1 (1.10–2.10 g/L)||1.73±0.32b||1.72±0.32a||1.69±0.28||0.786||0.760|
|S-Apo-B (0.50–1.70 g/L)||1.02±0.21||1.01±0.18a||1.06±0.17||0.954||0.003|
|Apo B/Apo-A1 (<1)||0.60±0.14b||0.61±0.17a||0.64±0.13||0.997||0.117|
|P-VWF (0.60–1.60 kIE/L)||1.11±0.40b||1.05±0.36b||1.07±0.40b||0.467||0.647|
|P-PAI-1 (<15 kIE/L)||10.07±6.90b||9.51±7.73b||8.69±7.49b||0.320||0.661|
|P-Homocysteine (5.0–15.0 µg/L)||9.30±3.00b||9.87±2.75a||9.59±2.29a||0.295||0.266|
|S-IGF-1 (110–270 µg/L)||137.5±52.9b||146.2±48.3a||143.6±68.2||0.323||0.086|
an = 47,
bn = 44–46.
cOne patient had CRP 35.40 mg/L at follow-up, after excluding the patient, mean hs-CRP was 1.26±1.09 mg/L, p<0.01. Values are shown as means±SD. F = female, P = plasma, S = serum, PTH = parathyroid hormone, S-Ca++ = ionised calcium, S-25-OH-D = 25 hydroxyvitamin D, GFR = glomerular filtration rate. P-hsCRP = high sensitivity C-reactive protein, TG = triglycerides, Apo = apolipoprotein, VWF = von Willebrand factor antigen, PAI-1 = plasminogen activator inhibitor-1 activity, IGF-1 = insulin like growth factor.
Table 3 Augmentation index and ultrasound measurements for healthy controls and patients with mild primary hyperparathyroidism before and after parathyroidectomy.
|Baseline||Follow-up||vs. Controls||vs. Follow-up|
|n = 48 (35 F)||n = 48 (35 F)||n = 48 (35 F)||p-value||p-value|
|Ao SBP, mmHg||109.8±15.3||114.4±17.3||114.8±15.8a||0.205||0.473|
|Ao DBP, mmHg||75.0±9.7||78.1±11.3||78.0±8.7a||0.097||0.181|
|IMTrad, mean, mm||0.255±0.053a||0.271±0.060c||0.271±0.046b||0.340||0.623|
|LDrad, mean, mm||1.87±0.35a||1.79±0.30c||1.90±0.38b||0.199||0.020|
|IMTcca, mean, mm||0.680±0.135||0.688±0.113||0.702±0.119a||0.354||0.172|
|LDcca, mean, mm||5.94±0.62||6.03±0.45||6.03±0.47a||0.229||0.197|
an = 47,
bn = 43–45,
cn = 36–41. Values are shown as means±SD. F = female, AIx = augmentation index, PWVao = aortic pulse wave velocity, Ao SBP = aortic systolic blood pressure, Ao DBP = aortic diastolic blood pressure, IMTrad = intima media thickness in right radial artery, LDrad = lumen diameter in right radial artery, IMTcca = intima media thickness in both left and right common carotid artery, LDcca = lumen diameter in both left and right common carotid artery, IM-GSM = intima media grayscale median in both left and right common carotid artery.
Table 4 Spearman rank order correlations between vascular variables and clinical and biochemical data in the whole group of PHPT patients and controls.
Statistically significant correlations; * = p<0.05, ** = p<0.01, *** = p<0.001.
AIx = augmentation index, PWVao = aortic pulse wave velocity, IMTrad = intima media thickness in right radial artery, IMTcca = intima media thickness in both left and right common carotid artery, IM-GSM = intima media grayscale median in both left and right common carotid artery, SBP = systolic blood pressure, bpm = beats per minutes, P = plasma, S = serum, S-Ca++ = ionized calcium, PTH = parathyroid hormone, S-25-OH-D = 25 hydroxyvitamin D, TG = triglycerides, Apo = apolipoprotein.
Table 5 Stepwise regression analyses with indices of vascular function as dependent variables, and demographic data as independent variables in the whole group of PHPT patients and controls.
|Variable||Model for AIx||Model for PWVao||Model for IMTcca||Model for IMTrad||Model for IM-GSM|
|R2 = 0.57, p<0.001||R2 = 0.37, p<0.001||R2 = 0.32, p<0.001||R2 = 0.08, p<0.01||R2 = 0.14, p<0.001|
AIx = augmentation index, PWVao = aortic pulse wave velocity, IMTcca = intima media thickness in both left and right common carotid artery, IMTrad = intima media thickness in right radial artery, IM-GSM = intima media grayscale median in both left and right common carotid artery, SBP = systolic blood pressure.
Table 6 Stepwise regression analyses with indices of vascular function as dependent variables, and demographic and biochemical data as independent variables in the whole group of PHPT patients and controls.
|Variable||Model for AIx||Model for PWVao||Model for IMTcca||Model for IMTrad||Model for IM-GSM|
|R2 = 0.58, p<0.001||R2 = 0.37, p<0.001||R2 = 0.29, p<0.001||R2 = 0.07, p<0.05||R2 = 0.18, p<0.001|
AIx = augmentation index, PWVao = aortic pulse wave velocity, IMTcca = intima media thickness in both left and right common carotid artery, IMTrad = intima media thickness in right radial artery, IM-GSM = intima media grayscale median in both left and right common carotid artery, SBP = systolic blood pressure, PTH = parathyroid hormone, P = plasma, S = serum, S-Ca++ = ionized calcium, PTH = parathyroid hormone, S-25-OH-D = 25 hydroxyvitamin D.
Previous Document: A new body shape index predicts mortality hazard independently of body mass index.
Next Document: N-acetylcysteine protects rats with chronic renal failure from gadolinium-chelate nephrotoxicity.